[go: up one dir, main page]

MD4009B1 - Use of 1-methyl-4-(N-methylaminobutyl-4)- Beta -carboline as antituberculous remedy - Google Patents

Use of 1-methyl-4-(N-methylaminobutyl-4)- Beta -carboline as antituberculous remedy Download PDF

Info

Publication number
MD4009B1
MD4009B1 MDA20080198A MD20080198A MD4009B1 MD 4009 B1 MD4009 B1 MD 4009B1 MD A20080198 A MDA20080198 A MD A20080198A MD 20080198 A MD20080198 A MD 20080198A MD 4009 B1 MD4009 B1 MD 4009B1
Authority
MD
Moldova
Prior art keywords
antituberculous
remedy
methylaminobutyl
carboline
beta
Prior art date
Application number
MDA20080198A
Other languages
Romanian (ro)
Other versions
MD4009C2 (en
Inventor
Fliur MACAEV
Eugenia Stangaci
Daniela Duca
Gheorghe DUCA
Original Assignee
Institutul De Chimie Al Academiei De Stiinte A Moldovei
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institutul De Chimie Al Academiei De Stiinte A Moldovei filed Critical Institutul De Chimie Al Academiei De Stiinte A Moldovei
Priority to MDA20080198A priority Critical patent/MD4009C2/en
Publication of MD4009B1 publication Critical patent/MD4009B1/en
Publication of MD4009C2 publication Critical patent/MD4009C2/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to chemistry, namely to the use of brevicarine alkaloid compound as antituberculous remedy. Summary of the invention consists in the use of 1-methyl-4-(N-methylaminobutyl-4)-Beta-carboline (brevicarine) of general formula:as antituberculous remedy.
MDA20080198A 2008-07-15 2008-07-15 Use of 1-methyl-4-(N-methylaminobutyl-4)-b-carboline as antituberculous remedy MD4009C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20080198A MD4009C2 (en) 2008-07-15 2008-07-15 Use of 1-methyl-4-(N-methylaminobutyl-4)-b-carboline as antituberculous remedy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20080198A MD4009C2 (en) 2008-07-15 2008-07-15 Use of 1-methyl-4-(N-methylaminobutyl-4)-b-carboline as antituberculous remedy

Publications (2)

Publication Number Publication Date
MD4009B1 true MD4009B1 (en) 2010-01-29
MD4009C2 MD4009C2 (en) 2010-08-31

Family

ID=43568882

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20080198A MD4009C2 (en) 2008-07-15 2008-07-15 Use of 1-methyl-4-(N-methylaminobutyl-4)-b-carboline as antituberculous remedy

Country Status (1)

Country Link
MD (1) MD4009C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4404C1 (en) * 2015-03-18 2016-09-30 Институт Химии Академии Наук Молдовы 2-(Propylthio)-5H-[1,3,4]thiadiazole[2,3-b]quinazoline-5-one compound, exhibiting antituberculous activity and method for synthesis thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4125C1 (en) * 2010-09-17 2012-03-31 Inst De Chimie Al Academiei De Stiinte A Moldovei 1,3,4-Oxadiazole compounds with antituberculous properties containing monosubstituted thiourea

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU859889A1 (en) * 1980-01-17 1981-08-30 Читинский Медицинский Институт Method of 1-methyl-4-(n-methylpyrrolidil-1)- -carbolene hydrochloride quantitative determination
US5817321A (en) * 1992-10-08 1998-10-06 Supratek Pharma, Inc. Biological agent compositions
CN1243767C (en) * 1999-03-23 2006-03-01 霍利斯-伊登医药公司 Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone
IT1311924B1 (en) * 1999-04-13 2002-03-20 Nicox Sa PHARMACEUTICAL COMPOUNDS.
IT1311923B1 (en) * 1999-04-13 2002-03-20 Nicox Sa PHARMACEUTICAL COMPOUNDS.
UA71629C2 (en) * 1999-08-03 2004-12-15 Lilli Icos Llc Composition containing free drug particulate form of ?-carboline (variants), method for its manufacture (variants), and method for treating sexual dysfunction
IT1314184B1 (en) * 1999-08-12 2002-12-06 Nicox Sa PHARMACEUTICAL COMPOSITIONS FOR THE THERAPY OF STRESS-OXIDATIVE CONDITIONS
DE19951360A1 (en) * 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituted indoles
IT1317735B1 (en) * 2000-01-26 2003-07-15 Nicox Sa SALTS OF ANTIMICROBIAL AGENTS.
UA74826C2 (en) * 2000-05-17 2006-02-15 Ortho Mcneil Pharm Inc ?-carboline derivatives as phosphodiesterase inhibitors
TW200403072A (en) * 2002-01-23 2004-03-01 Upjohn Co Combination therapy for the treatment of bacterial infections
UA78839C2 (en) * 2002-07-31 2007-04-25 Lilly Icos Llc Modified pictet-spengler reaction and products prepared therefrom
US20070269539A1 (en) * 2003-05-02 2007-11-22 Georgetown University Ginkgo Biloba Extract as a Treatment for Therapeutic-Induced Neurotoxicity
US20050148553A1 (en) * 2003-09-05 2005-07-07 Testa Raymond T. Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
EP1753427B1 (en) * 2004-05-28 2008-04-02 Janssen Pharmaceutica N.V. Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
TW200628161A (en) * 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4404C1 (en) * 2015-03-18 2016-09-30 Институт Химии Академии Наук Молдовы 2-(Propylthio)-5H-[1,3,4]thiadiazole[2,3-b]quinazoline-5-one compound, exhibiting antituberculous activity and method for synthesis thereof

Also Published As

Publication number Publication date
MD4009C2 (en) 2010-08-31

Similar Documents

Publication Publication Date Title
MY152114A (en) Novel pyrazole-4-n-alkoxycarboxamides as microbiocides
MX2010002243A (en) Fungicidal 2-alkylthio-2-quinolinyloxy-acetamide deritvatives.
MY153915A (en) Organic compounds
UA103625C2 (en) 5-hetrocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enons as herbicides
WO2007085895A3 (en) Fap inhibitors
WO2009024342A3 (en) Novel microbiocides
MX2010009416A (en) Heterocyclic compounds as inhibitors of cxcr2.
MY150542A (en) Cmet inhibitors
MY161132A (en) Novel herbicides
MX2011007998A (en) Novel herbicides.
TN2010000064A1 (en) Novel herbicides
UA102289C2 (en) Herbicides obtained of cyclopentadione
MX2010001364A (en) Novel herbicides.
MX2012008141A (en) Compounds and methods.
MX2011007932A (en) Novel herbicides.
WO2008151828A3 (en) Novel microbiocides
TN2011000355A1 (en) Novel microbiocides
MX2009013515A (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics.
UA101963C2 (en) 4-amino-pyrimidine derivatives
WO2009127718A3 (en) Novel microbiocides
TW200740814A (en) Compounds
IL189883A0 (en) Isoquinolines as igf-1r inhibitors
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
TN2009000536A1 (en) Novel herbicides
MX345142B (en) Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists.

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees